Figure 1.

Effects of TGs on risk of peripheral arterial revascularization in statin‐treated patients with high cardiovascular risk*. *Multivariate analysis using Cox proportional hazard model. Separate pre‐match multivariate analyses of peripheral arterial revascularization were performed. Covariates included triglyceride cohort, as represented here, along with age (45‐54, 55‐64, ≥65 years), sex, insurance coverage type, geographic region of enrollment, baseline clinical characteristics (diabetes, atherosclerotic cardiovascular disease, low‐density lipoprotein cholesterol laboratory result in relation to median), and baseline medication use (fibrate, prescription omega‐3, both, and neither). ^†Elevated triglycerides pre‐match cohort: TGs ≥150 mg/dL (n = 25 452 patients); comparator pre‐match cohort: TGs <150 mg/dL and high‐density lipoprotein cholesterol >40 mg/dL (n = 31 805 patients). ^ǂHigh TGs pre‐match cohort: TGs 200‐499 mg/dL (n = 12 364 patients); comparator pre‐match cohort: TGs <150 mg/dL and high‐density lipoprotein cholesterol >40 mg/dL (n = 31 805 patients). CI, confidence interval; TG, triglycerides